Dr. Ram Mani, MD

Dr. Mani practices at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health.

Dr. Mani's NPI, 1801003199, was assigned on May 17, 2007. Dr. Mani graduated from Geisel School of Medicine at Dartmouth in 2004. Dr. Mani holds New Jersey license 25MA08902600.

Dr. Mani's primary practice is Robert Wood Johnson University Hospital, at One Robert Wood Johnson Place, New Brunswick, NJ 08901 in Middlesex County. The practice phone is (732) 828-3000. Dr. Mani also practices at Robert Wood Johnson University Hospital - New Brunswick, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

Dr. Mani's primary practice is Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health. Dr. Mani is also affiliated with Trinitas Regional Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Mani to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mani practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Mani's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Mani's licenses on file in 3 states: New Jersey, Massachusetts and Pennsylvania.

CMS data shows 297 Medicare services from Dr. Mani across 5 procedure codes in 2024, for 234 Medicare patients. Medicare paid $35,221 for them.

CMS counts 234 Medicare patients who saw Dr. Mani in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mani's median patient age at 67, with 49% women.

In 2024, Dr. Mani wrote 376 Medicare Part D claims for 75 patients. 69% of them were for generic drugs. CMS names the drug for 258 of them, across 13 drugs with 11 or more claims each, at $85,545 in total drug cost. In 2023, CMS named 402 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Mani for performance year 2024, reported as part of a group. Dr. Mani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Mani, published from 2010 to 2024. 2012 was the busiest year, with 2. The most frequent topics are Electroencephalography, Epilepsy and Monitoring, Physiologic. Dr. Mani has published most often in Epilepsy Behav. Dr. Mani's most frequent co-authors are Brad K. Kamitaki, MD, Lisa M. Bateman, MD and Lawrence Charles Kleinman, MD.

Dmand AI links Dr. Mani to 1 clinical trial. Conditions studied include Epilepsy and Brain Diseases.

CMS Open Payments shows 16 general payments to Dr. Mani from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. UCB, Inc. paid the most, $1,364.

Dr. Mani graduated from Geisel School of Medicine at Dartmouth in 2004.